Renovaro Biosciences Inc (RENB)

Schlusskurs vom Vortag:

$1.04

Offen:

$1.13

24-Stunden-Volumen:

122.22K

Marktkapitalisierung:

$137.59M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-41.23M

KGV:

-1.3754

EPS:

-0.71

Netto-Cashflow:

$-11.54M

1W Leistung:

-33.12%

1M Leistung:

-60.14%

6M Leistung:

-67.50%

1J Leistung:

+0.00%

1-Tages-Spanne:

$0.90

$1.13

52-Wochen-Spanne:

$0.90

$5.25

Renovaro Biosciences Inc Stock (RENB) Company Profile

Firmenname

Renovaro Biosciences Inc

Sektor

Healthcare (1213)

Branche

Biotechnology (696)

Telefon

305 918 1980

Adresse

Century City Medical Plaza, Suite 906 2080 Century Park East, Los Angeles

Mitarbeiter

22

Twitter

Nächster Verdiensttermin

2024-05-13

Neueste SEC-Einreichungen

RENB's Discussions on Twitter

Renovaro Biosciences Inc Aktie (RENB) Neueste Nachrichten

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

GlobeNewswire Inc.

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care

GlobeNewswire Inc.

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

GlobeNewswire Inc.

Statement of Renovaro Inc

GlobeNewswire Inc.

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Finanzdaten der Renovaro Biosciences Inc-Aktie (RENB)

Renovaro Biosciences Inc (RENB) Nettogewinn 2024

Renovaro Biosciences Inc (RENB) Free Cashflow 2024

Renovaro Biosciences Inc (RENB) Gewinn je Aktie 2024